Julie Toll
Family Medicine · Houston, TXNPI 1306932595
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Novo Nordisk at 27.6% of the total. Reporting peaked in 2019 at $1,054 and has fallen 97.4% since, to $28 in 2022.
Across 91 payments — averaging $16.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$424
- AstraZeneca$161
- Pfizer$133
- Amarin Pharma, Inc.$104
- Teva Pharmaceuticals USA, Inc.$100
- AbbVie$99
- plus $514 from 16 others
What the payments were for
- Food & beverage$1,535100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 22 | $424 |
| AstraZeneca | 11 | $161 |
| Pfizer | 9 | $133 |
| Amarin Pharma, Inc. | 6 | $104 |
| Teva Pharmaceuticals USA, Inc. | 6 | $100 |
| AbbVie(2 entities) | 5 | $99 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $86 |
| Novartis | 4 | $72 |
| Abbott | 2 | $48 |
| Ironwood Pharmaceuticals, Inc | 2 | $41 |
| Merck | 3 | $35 |
| Astellas Pharma US Inc | 2 | $34 |
| Sanofi-aventis U.S. LLC | 2 | $33 |
| Boehringer Ingelheim | 2 | $33 |
| Lilly USA, LLC | 2 | $23 |
| Neos Therapeutics, LP | 1 | $18 |
| Genentech USA, Inc. | 1 | $17 |
| GSK | 1 | $16 |
| Optinose US, Inc. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Si-bone, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$222
How this compares
$1,535 in reported general payments places this provider in the 70th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Houston
- Shannon SchraderHouston$216K
- Candice WinfulHouston$173K
- Guljeet SohalHouston$72K
- Lakecia PittsHouston$71K
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.